Top compounds associated with response to THSD1


Feature Type Standardized
Nominal ANOVA
mRNA MGCD-265 CTRPv2 pan-cancer AAC 0.032 0.4
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.034 0.4
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.032 0.4
mRNA YK 4-279 CTRPv2 pan-cancer AAC -0.029 0.4
mRNA BRD8899 CTRPv2 pan-cancer AAC -0.034 0.4
mRNA tivantinib CTRPv2 pan-cancer AAC 0.042 0.4
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.033 0.4
mRNA FK866 CTRPv2 pan-cancer AAC 0.034 0.4
mRNA Mdivi-1 CTRPv2 pan-cancer AAC 0.032 0.4
mRNA YM-155 CTRPv2 pan-cancer AAC -0.034 0.4
Download CSV